Concepedia

Author

Bo Björkstrand

Karolinska Institutet

Also Known As

B Björkstrand, B. BJÖRKSTRAND, B. Bjorkstrand, B. Björkstrand, Björkstrand B, Bo Bjorkstrand, Bo Björkstrand, Bo Björkstrand, Bo T. Bjorkstrand

51

Publications

2.7K

Citations

23

H-Index

45

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalIntegrated Cardio Metabolic CentreUppsala University HospitalLund University
BB

About

Bo Björkstrand is an author at Karolinska Institutet specializing in medicine, cell transplantation, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

675

2

Health Sciences

5

5

290

3

Cellular Therapies

4

4

108

4

Blood Transplantation

3

3

225

5

Cell Biology

3

3

212

Bo Björkstrand

×

30

Publications

2.5K

Citations

21

H-Index

YearCitations

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

Gösta Gahrton, H. Svensson, Michèle Cavo,

British Journal of Haematology

2001

338

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Anders Waage, Peter Gimsing, Peter Fayers,

Blood

2010

231

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Evren Alici, Tolga Sütlü, Bo Björkstrand,

Blood

2008

195

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

Gösta Gahrton, Simona Iacobelli, Bo Björkstrand,

Blood

2013

190

Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.

M. Siraç Dilber, Mohammad R. Abedi, Bértil Christensson,

PubMed

1997

184

Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up

Bo Björkstrand, Simona Iacobelli, Ute Hegenbart,

Journal of Clinical Oncology

2011

183

Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning

Charles Crawley, Simona Iacobelli, Bo Björkstrand,

Blood

2006

181

Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry

Cecilie Blimark, Ingemar Turesson, Anna Genell,

Haematologica

2017

126

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)

Bo Björkstrand, H. Svensson, H. Goldschmidt,

Bone Marrow Transplantation

2001

99

Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.

Bo Björkstrand, Per Ljungman, J M Bird,

PubMed

1995

89

Page 1